These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 8188358)

  • 41. Parasitized erythrocyte membrane antigens of Plasmodium brasilianum: relationships with the ring-infected erythrocyte surface antigen of Plasmodium falciparum.
    Sulzer AJ; Collins WE; Cantella RA; Carney WP
    Am J Trop Med Hyg; 1995 Dec; 53(6):618-23. PubMed ID: 8561264
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-MSP11 IgG inhibits Plasmodium falciparum merozoite invasion into erythrocytes in vitro.
    Tohmoto T; Takashima E; Takeo S; Morita M; Nagaoka H; Udomsangpetch R; Sattabongkot J; Ishino T; Torii M; Tsuboi T
    Parasitol Int; 2019 Apr; 69():25-29. PubMed ID: 30385417
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alteration in host cell tropism limits the efficacy of immunization with a surface protein of malaria merozoites.
    Shi Q; Cernetich A; Daly TM; Galvan G; Vaidya AB; Bergman LW; Burns JM
    Infect Immun; 2005 Oct; 73(10):6363-71. PubMed ID: 16177307
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Suppression of lethal Plasmodium yoelii malaria following protective immunization requires antibody-, IL-4-, and IFN-gamma-dependent responses induced by vaccination and/or challenge infection.
    Petritus PM; Burns JM
    J Immunol; 2008 Jan; 180(1):444-53. PubMed ID: 18097046
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Plasmodium yoelii microgamete surface antigen (PyMiGS) induces anti-malarial transmission blocking immunity that reduces microgamete motility/release from activated male gametocytes.
    Tachibana M; Ishino T; Tsuboi T; Torii M
    Vaccine; 2018 Nov; 36(49):7463-7471. PubMed ID: 30420038
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Study on protective immunity against infection of Plasmodium yoelii 17XL in DBA/2 mice.
    Zheng W; Liu J; Meng DY; Hu XF; Cao YM
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2006 Feb; 24(1):14-8. PubMed ID: 16866134
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity.
    Singh S; Miura K; Zhou H; Muratova O; Keegan B; Miles A; Martin LB; Saul AJ; Miller LH; Long CA
    Infect Immun; 2006 Aug; 74(8):4573-80. PubMed ID: 16861644
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An unusual tryptophan-rich domain characterizes two secreted antigens of Plasmodium yoelii-infected erythrocytes.
    Burns JM; Adeeku EK; Belk CC; Dunn PD
    Mol Biochem Parasitol; 2000 Sep; 110(1):11-21. PubMed ID: 10989141
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of the merozoite surface protein 4/5 gene of Plasmodium berghei and Plasmodium yoelii.
    Kedzierski L; Black CG; Coppel RL
    Mol Biochem Parasitol; 2000 Jan; 105(1):137-47. PubMed ID: 10613706
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro antibody response to the tetrapeptide repeats of Plasmodium falciparum circumsporozoite protein by splenocytes from mice infected with P. yoelii yoelii.
    Kobayashi F; Tsuji M; Weidanz WP
    J Vet Med Sci; 2001 Jul; 63(7):743-9. PubMed ID: 11503901
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunoglobulin G isotype responses to erythrocyte surface-expressed variant antigens of Plasmodium falciparum predict protection from malaria in African children.
    Yone CL; Kremsner PG; Luty AJ
    Infect Immun; 2005 Apr; 73(4):2281-7. PubMed ID: 15784572
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
    Burns JM; Miura K; Sullivan J; Long CA; Barnwell JW
    Malar J; 2016 Mar; 15():159. PubMed ID: 26975721
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Correlation of high levels of antibodies to multiple pre-erythrocytic Plasmodium falciparum antigens and protection from infection.
    John CC; Moormann AM; Pregibon DC; Sumba PO; McHugh MM; Narum DL; Lanar DE; Schluchter MD; Kazura JW
    Am J Trop Med Hyg; 2005 Jul; 73(1):222-8. PubMed ID: 16014863
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The glutamate-rich protein (GLURP) of Plasmodium falciparum is a target for antibody-dependent monocyte-mediated inhibition of parasite growth in vitro.
    Theisen M; Soe S; Oeuvray C; Thomas AW; Vuust J; Danielsen S; Jepsen S; Druilhe P
    Infect Immun; 1998 Jan; 66(1):11-7. PubMed ID: 9423833
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cross-Species Immune Recognition Between Plasmodium vivax Duffy Binding Protein Antibodies and the Plasmodium falciparum Surface Antigen VAR2CSA.
    Gnidehou S; Mitran CJ; Arango E; Banman S; Mena A; Medawar E; Lima BAS; Doritchamou J; Rajwani J; Jin A; Gavina K; Ntumngia F; Duffy P; Narum D; Ndam NT; Nielsen MA; Salanti A; Kano FS; Carvalho LH; Adams JH; Maestre A; Good MF; Yanow SK
    J Infect Dis; 2019 Jan; 219(1):110-120. PubMed ID: 30534974
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Functional Comparison of Blood-Stage
    Illingworth JJ; Alanine DG; Brown R; Marshall JM; Bartlett HE; Silk SE; Labbé GM; Quinkert D; Cho JS; Wendler JP; Pattinson DJ; Barfod L; Douglas AD; Shea MW; Wright KE; de Cassan SC; Higgins MK; Draper SJ
    Front Immunol; 2019; 10():1254. PubMed ID: 31214195
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro development of infectious liver stages of P. yoelii and P. berghei malaria in human cell lines.
    Calvo-Calle JM; Moreno A; Eling WM; Nardin EH
    Exp Parasitol; 1994 Nov; 79(3):362-73. PubMed ID: 7957756
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Linear and multiple antigen peptides containing defined T and B epitopes of the Plasmodium yoelii circumsporozoite protein: antibody-mediated protection and boosting by sporozoite infection.
    Marussig M; Rénia L; Motard A; Miltgen F; Pétour P; Chauhan V; Corradin G; Mazier D
    Int Immunol; 1997 Dec; 9(12):1817-24. PubMed ID: 9466309
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antibodies against a Plasmodium falciparum antigen PfMSPDBL1 inhibit merozoite invasion into human erythrocytes.
    Sakamoto H; Takeo S; Maier AG; Sattabongkot J; Cowman AF; Tsuboi T
    Vaccine; 2012 Mar; 30(11):1972-80. PubMed ID: 22248820
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Model for in vivo assessment of humoral protection against malaria sporozoite challenge by passive transfer of monoclonal antibodies and immune serum.
    Sack BK; Miller JL; Vaughan AM; Douglass A; Kaushansky A; Mikolajczak S; Coppi A; Gonzalez-Aseguinolaza G; Tsuji M; Zavala F; Sinnis P; Kappe SH
    Infect Immun; 2014 Feb; 82(2):808-17. PubMed ID: 24478094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.